Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,862 papers from all fields of science
Search
Sign In
Create Free Account
U-90152
Known as:
U90152S
, U90152
, U 90152S
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Delavirdine
Delavirdine Mesylate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Synthesis of nucleoside analogs and new Tat protein inhibitors
A. Ané
,
G. Prestat
,
+6 authors
D. Dubreuil
2001
Corpus ID: 8109943
Two studies, concerning the synthesis of original nucleoside analogs regarded as an application of heterochemistry on…
Expand
1996
1996
Concomitant combination therapy for HIV infection preferable over sequential therapy with 3 TC and non-nucleoside reverse transcriptase inhibitors ( lamivudine y HIV-1 y resistance y combination…
J. Balzarini
,
H. Pelemans
,
A. Karlsson
,
E. Clercq
,
J. Kleim
1996
Corpus ID: 22680486
Exposure to 3TC of HIV-1 mutant strains containing non-nucleoside reverse transcriptase inhibitor (NNRTI)-specific mutations in…
Expand
1995
1995
Simultaneous mutations at Tyr‐181 and Tyr‐188 in HIV‐1 reverse transcriptase prevents inhibition of RNA‐dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U‐90152s
N. Fan
,
K. Rank
,
D. Evans
,
Richard C. Thomas
,
W. Gary Tarpley
,
Satish K. Sharma
FEBS Letters
1995
Corpus ID: 24836460
1994
1994
Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1…
K. Chong
,
P. Pagano
,
R. Hinshaw
Antimicrobial Agents and Chemotherapy
1994
Corpus ID: 24620102
Bisheteroarylpiperazine compounds are nonnucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 (HIV…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE